drugset / Trial / NCT01804400

A Clinical Trial to Test How Well Two Drugs, QAW039 and Montelukast Work Both Individually and Together, to Target Allergic Rhinitis Using an Environmental Exposure Chamber

NCT01804400

Phase 2 Completed 188 enrolled Novartis Pharmaceuticals
RandomizedCrossoverDouble-blindTreatment

Summary

This study will assess the safety and efficacy of QAW039 alone and in combination with Montelukast in patients with allergic rhinitis (hay fever) using an environmental exposure chamber.

Timeline

Start
2012-10
Primary completion
2013-10
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Montelukast Other / unclassified
Subject fevipiprant Small molecule

Indications